Charles Antzelevitch Selected Research

Ranolazine

10/2016	Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.
7/2014	Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
1/2012	Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
11/2011	Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation.
8/2011	Electrophysiologic basis for the antiarrhythmic actions of ranolazine.
10/2010	Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
2/2010	Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
5/2008	Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?
9/2007	Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
5/2007	Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles Antzelevitch Research Topics

Disease

50	Brugada Syndrome 05/2022 - 02/2002
29	Atrial Fibrillation 01/2020 - 09/2007
27	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2004
18	Ventricular Tachycardia 01/2018 - 08/2004
15	Torsades de Pointes (Torsade de Pointes) 12/2021 - 02/2003
14	Long QT Syndrome 01/2018 - 02/2002
11	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 02/2006
10	Heart Failure 07/2014 - 02/2003
7	Ventricular Fibrillation 01/2018 - 04/2002
6	Channelopathies 12/2021 - 08/2004
5	Timothy syndrome 12/2016 - 05/2007
5	Premature Cardiac Complexes (Extrasystoles) 11/2013 - 01/2003
5	Ischemia 12/2011 - 10/2005
4	Heart Arrest (Cardiac Arrest) 06/2018 - 05/2005
4	Bradycardia 10/2016 - 02/2006
4	Tachycardia (Tachyarrhythmias) 10/2011 - 02/2006
4	Short Qt Syndrome 05/2011 - 04/2004
3	Polymorphic catecholergic ventricular tachycardia 01/2022 - 05/2005
3	Heart Diseases (Heart Disease) 01/2020 - 01/2008
3	Sudden Infant Death (SID) 01/2018 - 04/2010
3	Sudden Death 04/2012 - 10/2005
3	Hyperkalemia 02/2006 - 02/2005
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Migraine Disorders (Migraine) 12/2020 - 07/2015
2	Hypothermia 01/2020 - 02/2014
2	Fever (Fevers) 06/2018 - 01/2016
2	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2017 - 02/2010
2	Syncope (Fainting) 02/2016 - 02/2010
2	Rhabdomyolysis 01/2014 - 02/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2013 - 04/2012
2	Inflammation (Inflammations) 01/2012 - 07/2009
2	Acute Coronary Syndrome 08/2011 - 05/2008
2	Andersen Syndrome 02/2011 - 03/2006
2	Cardiomyopathies (Cardiomyopathy) 09/2007 - 04/2006
2	Hypercalcemia (Milk Alkali Syndrome) 04/2005 - 02/2005
1	Acute Pain 12/2021
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 07/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia) 01/2018
1	Sick Sinus Syndrome 01/2018
1	Shock 02/2016

Drug/Important Bio-Agent (IBA)

30	Sodium Channels (Sodium Channel)IBA 05/2022 - 02/2002
16	Pharmaceutical PreparationsIBA 01/2021 - 12/2003
13	Ranolazine FDA Link 10/2016 - 08/2004
12	Ion Channels (Ion Channel)IBA 12/2021 - 02/2002
11	Quinidine (Chinidin)FDA LinkGeneric 12/2021 - 01/2005
9	CalciumIBA 01/2020 - 05/2003
9	SodiumIBA 01/2018 - 07/2004
8	Calcium Channels (Calcium Channel)IBA 01/2016 - 07/2004
7	Sodium Channel BlockersIBA 01/2020 - 01/2005
6	PotassiumIBA 01/2022 - 05/2004
6	Amiodarone (Amiodarona)FDA LinkGeneric 11/2011 - 01/2008
5	Ajmaline (Wolfina)FDA Link 01/2020 - 01/2004
5	Antidepressive Agents (Antidepressants)IBA 08/2018 - 02/2005
5	Anti-Arrhythmia AgentsIBA 03/2008 - 04/2004
4	Flecainide (Tambocor)FDA LinkGeneric 07/2020 - 04/2004
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2008
4	1- (3,5- bis- trifluoromethylphenyl)- 3- (2,4- dibromo- 6- (1H- tetrazol- 5- yl)phenyl)ureaIBA 01/2020 - 03/2009
4	wenxin keliIBA 03/2016 - 01/2012
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016 - 01/2005
4	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2012 - 09/2008
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 05/2005
3	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 12/2016 - 01/2007
3	Cilostazol (Pletal)FDA LinkGeneric 01/2016 - 11/2013
3	Milrinone (Primacor)FDA LinkGeneric 01/2016 - 11/2013
3	Terfenadine (Seldane)IBA 03/2006 - 01/2003
2	Voltage-Gated Sodium ChannelsIBA 07/2020 - 01/2019
2	Verapamil (Calan)FDA LinkGeneric 01/2020 - 03/2006
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 05/2003
2	Antipsychotic Agents (Antipsychotics)IBA 08/2018 - 03/2008
2	Bepridil (Vascor)FDA Link 01/2017 - 01/2016
2	Potassium Channels (Potassium Channel)IBA 04/2012 - 10/2005
2	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 03/2012 - 04/2004
2	Adenosine (Adenocard)FDA LinkGeneric 10/2011 - 02/2006
2	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 02/2011 - 03/2006
2	Dronedarone FDA Link 10/2010 - 09/2010
2	Adenosine Triphosphate (ATP)IBA 10/2010 - 03/2006
2	RyanodineIBA 05/2005 - 05/2003
2	Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)IBA 04/2005 - 02/2005
2	Glucose (Dextrose)FDA LinkGeneric 04/2005 - 02/2005
2	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 04/2005 - 02/2005
2	Insulin (Novolin)FDA Link 04/2005 - 02/2005
2	Cocaine (Cocaine HCl)IBA 04/2005 - 02/2005
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022
1	Dantrolene (Dantrium)FDA LinkGeneric 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 12/2021
1	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 12/2021
1	LigandsIBA 12/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	(R)- N- (benzimidazol- 2- yl)- 1,2,3,4- tetrahydro- 1- naphthylamineIBA 01/2020
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2020

Therapy/Procedure

18	Therapeutics 01/2020 - 02/2003
6	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 02/2016 - 11/2002
3	Radiofrequency Ablation 01/2018 - 01/2016
3	Cardiac Resynchronization Therapy 12/2005 - 02/2003
2	Defibrillators (Defibrillator) 06/2018 - 03/2006
2	Anesthesia 11/2012 - 09/2006
2	Transplantation 03/2012 - 04/2006
2	Drug Therapy (Chemotherapy) 04/2008 - 04/2004